Estimations des analystes de Wall Street pour Eledon Pharmaceuticals, Inc. (ELDN): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-13 | $-0.20 | ||
| 2026-08-13 | $-0.27 | $-0.16 | -70.9% |
| 2026-05-13 | $-0.33 | $-0.22 | -50.0% |
| 2026-03-19 | $-0.10 | $-0.20 | +50.0% |
| 2025-11-14 | $-0.21 | $-0.22 | +4.5% |
| 2025-08-14 | $-0.13 | $-0.23 | +43.5% |
| 2025-05-14 | $-0.08 | $-0.28 | +71.4% |
| 2025-03-20 | $-0.64 | $-0.32 | -100.0% |
Ratios de valorisation
| Prix / Valeur comptable | 4.21 |
| EV / EBITDA | -2.80 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coût des Ventes | $35000 | $22000 | $11000 | $182000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Marge Brute | -$35000 | -$22000 | -$11000 | -$182000 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D | $25.0M | $2.0M | $6.8M | $8.1M | $6.1M | $23.7M | $27.1M | $30.3M | $52.0M | $66.3M |
| Frais Généraux | $13.1M | $11.1M | $7.2M | $5.9M | $10.1M | $13.1M | $12.7M | $12.7M | $18.6M | $17.0M |
| Charges Opérationnelles | $38.1M | $13.1M | $14.1M | $14.0M | $18.5M | $36.9M | $88.4M | $43.0M | $70.6M | $83.3M |
| Résultat Opérationnel | -$38.1M | -$13.1M | -$14.1M | -$14.2M | -$18.5M | -$36.9M | -$88.4M | -$43.0M | -$70.6M | -$83.3M |
| EBITDA | -$6.9M | -$13.1M | -$14.0M | -$15.8M | -$16.0M | -$36.7M | -$39.4M | -$116.2M | -$35.4M | -$45.3M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | $9.7M | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$38.0M | -$13.1M | -$14.1M | -$16.0M | -$23.2M | -$36.9M | -$88.0M | -$116.5M | -$35.8M | -$45.6M |
| Impôts | $136000 | 0 | -$5000 | 0 | -$404000 | -$2.4M | 0 | 0 | $431000 | $35000 |
| Résultat Net | -$38.0M | -$13.1M | -$14.1M | -$16.0M | -$22.8M | -$34.5M | -$88.0M | -$116.5M | -$36.2M | -$45.6M |
| BPA | $-398.52 | $-41.40 | $-28.11 | $-24.42 | $-17.16 | $-2.33 | $-6.16 | $-4.73 | $-0.75 | $-0.56 |
| BPA Dilué | $-398.52 | $-41.40 | $-28.11 | $-24.42 | $-17.16 | $-2.33 | $-6.16 | $-4.73 | $-0.75 | $-0.56 |
| Actions en Circulation (Diluées) | $4.2M | $4.7M | $9.0M | $11.8M | $15.2M | $14.8M | $14.3M | $24.6M | $48.5M | $81.8M |
Prix
| Prix | $2.67 |
| Capitalisation | $206M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ABEO · ACHV · ALLO · AVIR · EDIT · HUMA · PBYI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ELDN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions